Oruka Therapeutics, Inc.
Nasdaq ORKA · Menlo Park, CA
Works in Dermatology · Infectious disease
Oruka Therapeutics, Inc. is a clinical trial sponsor based in Menlo Park, CA, listed as Nasdaq ORKA. It has 5 active clinical trials with 840 planned participants, in Dermatology and Infectious disease. Since 2021 it has completed 2 trials and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq ORKA
Fundraising
Pipeline · 5 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Oruka Therapeutics, Inc
Oruka Therapeutics, Inc is lead sponsor of 5 active clinical trials on ClinicalTrials.gov, with 840 planned participants, in Dermatology, Infectious disease. Since 2021 it has completed 2 trials and stopped 0 early.
Oruka Therapeutics, Inc is based in Menlo Park, CA and is listed as Nasdaq ORKA. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Oruka Therapeutics, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-16.
Approve Suite is not affiliated with Oruka Therapeutics, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.